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ing history, and medications were considered. Beta-blocker therapy was also
independently associated with decreased VE by multiple regression analysis. Conclu-
sion. Beta-blocker therapy decreases VE and increases ventilatory efficiency at rest and
during exercise in CHF pts which may contribute to improved functional class and quality
of life.
1165-104 Somatosensory Stimulation as an Alternative for 
Exercise to Enhance the Arterial Baroreflex
Cees A. Swenne, Yiping Sun, Liming Han, Martin J. Schalij, Henk J. Van Exel, Caroline M 
H B Lucas, Arie C. Maan, Harriette F. Verwey, Hedde Van de Vooren, Ernst E. Van der 
Wall, Leiden University Medical Center, Leiden, The Netherlands
Background. Arterial baroreflex sensitivity has important prognostic value in cardiovas-
cular disease. Patients should exercise because baroreflex sensitivity decreases with
physical inactivity, however, disease oftentimes seriously reduces exercise tolerance.
Here, we demonstrate that exercise-mimicking somatosensory stimulation alone, hence
without any actual exercise, is sufficient for arterial baroreflex improvement.
Methods. Before-after intervention trial conducted in the Leiden University Medical Cen-
ter between September 2001 and July 2002 in 21 (15 male and 6 female) randomly
selected outpatients with stable chronic heart failure (mean ± SD age 61.2 ± 11.4 years,
New York Heart Association heart failure class 2.1 ± 0.7). Intervention consisted of one
hour of somatosensory stimulation (by transcutaneous electrical nerve stimulation), at
walking pace, of nerves conducting ergoreceptor information from the feet. Core ses-
sions (control-, intermediate-, effect-) of the study were held at three consecutive days.
Rehearsal- and residue-effect sessions were held one week before and one week after
the core sessions, respectively. Somatosensory stimulation was applied during the
rehearsal-, control-, and intermediate sessions.
Results. Baroreflex sensitivity (reflex increase of the interval between heart beats per
mmHg systolic blood pressure rise) increased (P=0.016) by 57% from 3.57 ± 1.98 (con-
trol session) to 5.60 ± 2.79 (effect session) ms/mmHg. Baroreflex sensitivity in the resi-
due session did not differ significantly from the control session value.
Conclusions. In chronic heart failure patients, the arterial baroreflex can readily be
enhanced by exercise-mimicking somatosensory stimulation without any muscular
involvement. This finding supports the concept that exercise-associated sensations alone
- hence, apart from any actual exercise - are able to bring about training effects in the
autonomic nervous system, in congestive heart failure, but possibly also in other patient
groups. Follow-up studies should be done to establish the concrete health benefits of
somatosensory stimulation for those who cannot exercise.
1165-105 Exercise Training Reduces Vascular Inflammation in 
Patients With Cardiovascular Risk or Disease
Alexander Niessner, Bernhard Richter, Martina Penka, Sabine Steiner, Barbara Strasser, 
Sophie Ziegler, Elke Heeb-Elze, Gerlinde Zorn, Angelika Leitner-Heinschink, Johann 
Wojta, Kurt Huber, University of Vienna, Vienna, Austria
Background: The aim of our study was to investigate if reduced cardiovascular risk due
to endurance training is partly mediated by decreased vascular inflammation.
Methods: We studied 32 humans (f/m: 19:13, 31-58 yrs) with elevated cardiovascular
risk (CVR: n = 22, cholesterol > 200 mg/dl: 68%, DM: 59%, hypertension: 27%, BMI > 30:
18%, smoker: 9%) or proven coronary heart disease (CHD: n = 10, CCS < II). They par-
ticipated in a controlled training (endurance running) of 12 weeks (3-4 hrs/w). Circulating
IL-6, high sensitivity C-reactive protein (hsCRP), soluble CD40 ligand (sCD40L), mono-
cyte chemotactic protein 1 (MCP-1), and IL-8 were determined before (B) and after (A)
the training (after 48 hrs of rest) by immunoassays. In addition, we compared A values to
sedentary controls (C) matched for age, sex and disease. We decided to use parametric
(P: mean + SD, paired T-Test) or nonparametric analysis (NP: median [25th, 75th percen-
tile], Wilcoxon Signed Ranks Test) based on the Kolmogorov-Smirnov Test.
Results: The effect of training was confirmed by a 13.7 % mean decrease of time for a 2
km test-run with the individual training`s heart rate. MCP-1 (P: 213 + 50 vs 193 + 65.6 pg/
ml, p = .034) and IL-8 (NP: 88.5 [13.4, 1177] vs 42.5 [17.2, 968] pg/ml, p = .043) but not
IL-6 (p = .26), hsCRP (p = .67), and sCD40L (p = .11) decreased in response to training.
However, IL-6 (NP: 4 [2.1, 5.4] vs 1.4 [0, 4.9] pg/ml), p = .013), hsCRP (NP: 5.2 (1.5-7.1)
vs 0.9 (0.6-2.1) mg/l, p = .001), and sCD40L (NP: 10.53 [5.87, 14.43] vs 0 [0, 4.1] ng/ml,
p = .001) were significantly higher in sedentary controls compared to A. Changes of
inflammatory markers were not significantly different between subgroups with CVR and
CHD. Controls showed worse levels of HDL cholesterol (p = .004) and triglycerides (p =
.012) and smoked more often (χ2, p = .008). The use of aspirin, statins, ACE-inhibitors
and ARBs did not differ (χ2, n.s.).
Conclusion: An endurance training of 12 weeks decreased circulating chemotactic fac-
tors, which could lead to a more stable composition of atherosclerotic plaques by reduc-
ing inflammatory cells. Reduced sCD40L, IL-6 and hsCRP levels in physically active men
are rather caused by general and long-lasting life-style modification.
1165-106 Outpatient Clinic Base Therapeutic Program of Exercise 
After Heparin Administration for Patients With 
Arteriosclerosis Obliterans
Takanori Yasu, Taishi Hirahara, Yasuhiro Maejima, Hiroto Ueba, Nahoko Ikeda, Akihiro 
Kakehashi, Masatoshi Kuroki, Masanobu Kawakami, Muneyasu Saito, Omiya Medical 
Center, Jichi Medical School, Saitama, Japan
OBJECTIVES: We did a prospective study to examine a hypothesis that exercise pro-
gram combined with heparin administration improves clinical symptoms of patients with
arteriosclerosis obliterans (ASO) compared with exercise only in out-patient-clinic base.
METHODS: Consecutive 18 patients with symptomatic “no option” (inoperable) ASO
(Fontaine grade 2-3) diagnosed by angiography were randomly assigned to two groups;
a group of heparin and exercise (walking for 60 min after intravenous injection of 3,000
units of heparin three days a week for three months, n=9) and a group of exercise only
(n=9). Ankle brachial pressure index (ABI) and Treadmill exercise test (2.5 km/h, 10%
slope) were done before, 2 weeks, 12 weeks, and 24 weeks after the beginning of treat-
ment. Ophthalmic examinations including visual acuity test, ocular fundoscopy and fluo-
rescein angiographic fundus photography, and digital subtraction angiography of lower
extremities, and assessment of quality of life using SF36 score were repeated before and
24 weeks after the start of program.
RESULTS: Maximum walking time significantly increased in the group of exercise and
heparin compared with the group of exercise both at 12 weeks and 24 weeks. There was
no significant differences in ABI between two groups through the study period. Although
only two out of seven patients (22%) showed increased collateral flow in the group of
exercise at 24 weeks, five patients (56%) showed increased collateral vessel flow in the
group exercise and heparin. There were no patients who showed pathological retinal
angiogenesis.
CONCLUSION: Exercise program combined with heparin administration improves clini-
cal symptoms of ASO partly via accelerating angiogenesis without exacerbation of dia-
betic retinopathy.
1165-107 Measurement Versus Calculation of Training Heart Rate 
in Patients With Coronary Artery Disease Treated by 
Beta-Blockers
Philippe Meurin, Ahmed Bendriss, Helene Weber, Gabriel Thabut, Benedicte Zamblera, 
Dominique Odjinkem, Nathalie Renaud, Jean Yves Tabet, Les Grands Pres, Villeneuve 
Saint Denis, France
Background : In patients with coronary artery disease, target intensity-level of exercise
training is usually adjusted by a training heart rate (THR) which aims to be closed to the
anaerobic threshold heart rate.
THR should be measured during an exercise test with gas analysis but it is usually calcu-
lated from the Karvonen “formula” after a conventional exercise test : THRc = 0.6x(MHR-
RHR) + RHR; THRc = calculated Training Heart Rate, MHR = Maximal Heart Rate,
RHR=Resting Heart Rate. However this “formula” was only assessed in 6 normal sub-
jects.
The aim of this study is to evaluate whether a THR calculation after a regular exercise
test is reliable in patients treated with beta-blockers.
Methods : Multicentric prospective study; Patients underwent an exercise test with gas
analysis (with a ramp protocol, 10w/min) HR at the anaerobic threshold was measured
(THRm : measured Training Heart Rate) and was compared to THRc .
Results: 86 consecutive patients 56 + 20 years old were included, 20 + 5 days after an
acute myocardial infarction. All were treated with beta blockers. Left ventricular ejection
fraction was 48 + 5%.
Patients heart rate measured at AT (Mean THRm = 102 + 18 bpm) was significantly
greater than THRc (91 + 15 bpm; p = 0.0008).
THRm was more than 10 % above THRc in 50 % of the patients (patients undertrained if
the Karvonen formula is used ; fig 1);
Using a “Karvonen modified formula” : THR = 0.9x(MHR-RHR) + RHR allows calculating
a HR closer to the THRm (r = 0.91, p<0.0001)
Conclusion
Using The Karvonen “formula” in betablockers treated patients may lead to undertrain
patients after MI; this “formula” should be adapted in these patients to predict more accu-
rately heart rate at the anaerobic threshold.
1165-108 Prevalence and Effects of Cardiac Rehabilitation on 
Hostility in Young Coronary Patients
Carl J. Lavie, Richard V. Milani, Gail Brewer, Ochsner Clinic Foundation, New Orleans, 
LA
Background: We and others have published studies indicating that hostility is a significant
CAD risk factor and adversely affects recovery after major CAD events. However, no data
exists on the prevalence of hostility in various subgroups of CAD patients or on the
effects of cardiac rehabilitation and exercise training (CR/ET) on them.
Methods: Using the Kellner Symptom Questionnaire, a validated measure to assess vari-
ous behavioral characteristics, and the MOS-SF36 to assess quality of life (QoL), we
studied 81 young CAD patients (<50 years; 45 ± 5 years) and 268 elderly (>= 65 years;
70 ± 4 years) for hostility scores, prevalence of high hostility (HH; symptom score > 7
units), other CAD risk factors, and response to Phase II CR/ET programs.
Results: Hostility scores were considerably higher in the young than in the elderly (5.6 ±
6.0 vs. 2.1 ± 3.2 units; p<0.01) and the prevalence of HH was 3.5 times higher in younger
patients (28% vs. 8%; p<0.01). Young with HH had higher total cholesterol (TC; 232 ± 55
vs. 195 ± 41 mg/dl; p<0.01), triglycerides (400 ± 501 vs. 179 ± 83 mg/dl; p<0.01), TC/
HDL ratio (7.5 ± 3.6 vs. 5.9 ± 1.7; p<0.01), fasting glucose (141 ± 70 vs. 104 ± 21 mg/dl;
p<0.001), glycosylated hemoglobin (6.4 ± 2.0 vs. 5.6 ± 0.9%; p=0.03), and lower QoL (88
± 13 vs. 103 ± 16 units; p<0.001) compared with young with low hostility. Following CR/
ET, young with HH had marked improvements in TC (-15%; p<0.01), triglycerides (-53%;
p<0.01), TC/HDL (-23%; p<0.001), hostility score (-43%; p<0.01), and QoL (+26%;
p<0.0001), as well as improvements in other CAD risk factors. Compared with young with
LH, those with HH have significantly greater improvements in TC (p<0.01), body mass
indices (p<0.05), hostility score (p=0.03), and QoL (p<0.01) following CR/ET.
Conclusion: Young coronary patients have a high prevalence of high hostility and these
patients have quite adverse CAD profiles compared with other patients. Greater empha-
sis is needed on reducing hostility and other parameters of psychological distress in
young CAD patients as well as the potential benefits of CR/ET in the secondary preven-
tion of CAD.
